Clomiphene citrate therapy of infertile women with low luteal phase progesterone levels

Obstetrics and Gynecology, 59(3), 275-279

Source

Abstract

Sixty-nine infertile women with a midluteal serum progesterone level of 4 to 14 ng/ml were treated with a graduated dosage schedule of clomiphene citrate until the progesterone level on day 21 was greater than 20 ng/ml. Thirty-one pregnancies occurred, 58% during the first adequate treatment cycle and 19% during the second cycle. The abortion rate was 23%. After 6 adequate treatment cycles, laparoscopic evaluation was performed on 28 of 39 patients who did not conceive. Pathology was noted in 57%. Seven of 17 patients with intraperitoneal causes of infertility conceived after alternative therapy. The corrected pregnancy rate was 60%. Results of this study suggest that low luteal phase progesterone levels may compromise fertility and that clomiphene citrate enhances pregnancy rates.

Topics

clomiphene citrate low luteal progesterone infertility treatment, luteal phase deficiency clomiphene graduated dosage pregnancy rate, Hammond Talbert clomiphene citrate luteal phase defect, midluteal serum progesterone less than 15 clomiphene therapy, clomiphene citrate day 21 progesterone greater than 20, clomiphene infertility treatment laparoscopic evaluation non-responders, luteal phase deficiency ovulation induction pregnancy outcomes, low progesterone infertility corrected pregnancy rate 60 percent, clomiphene citrate first cycle conception rate infertility, intraperitoneal pathology unexplained infertility after clomiphene failure

Cite this article

Hammond, M. G., & Talbert, L. M. (1982). Clomiphene citrate therapy of infertile women with low luteal phase progesterone levels. *Obstetrics and gynecology*, *59*(3), 275-279.

Related articles